ATROB

ATROB remains in a Stage 4 decline with medium-term bearish asymmetry. The asset is trading below the 9 EMA, 21 EMA, and 50 DMA, with failed rally attempts indicating persistent selling pressure. Although a Bearish Exhaustion pattern suggests potential stabilization, overall momentum and Stage 4 context favor continued downtrend. Execution should be deferred to rallies into short-term EMA resistance zones for trimming positions.

• ↑Q1 EPS $0.59 vs $0.57 est and revenue $231M vs $227.8M est
• ↑Analysts expect ~7.1% annual revenue growth to $1.1B by 2029
• ↓P/E ratio 76.4x markedly above aerospace & defense avg of 40.3x